Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting Clinical rheumatology and osteoporosis

BMC Musculoskeletal Disorders

Volumn 16, Issue 1, 2015, Pages 1-8

  Jafri, Kashif ^a   Taylor, Lynne ^b   Nezamzadeh, Melissa ^b   Baker, Joshua F ^b   Mehta, Nehal N ^c   Bartels, Christie ^d   Williams, Catherine T ^b   Ogdie, Alexis ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; COLESEVELAM; COLESTYRAMINE; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EZETIMIBE; FENOFIBRATE; FISH OIL; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; LIPID; MEVINOLIN; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PRAVASTATIN; RHEUMATOID FACTOR; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE DURATION; DRUG INDICATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ICD-9; LIPID ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK MANAGEMENT; SCREENING TEST; TREATMENT INDICATION; UNITED STATES; AGED; ARTHRITIS, RHEUMATOID; DISEASE MANAGEMENT; HYPERLIPIDEMIAS; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; VALIDATION STUDY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84941170595     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0700-5     Document Type: Article

References (30)

1. Aviña-Zubieta J, Choi H, Sadatsafavi M, Etminan M, Esdaile J, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-7.
2. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a populationbased cohort study. Arth Rheum. 2005;52:402-11.
3. Solomon D, Goodson N, Katz J, Weinblatt M, Avorn J, Setoguchi S, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 2006;65:1608-12.
4. Rasch E, Hirsch R, Paulose-Ram R, Hochberg M. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arth Rheum. 2003;48(4):917-26.
5. Crowson C, Matteson E, Roger V, Therneau T, Gabriel S. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol. 2012;110(3):420-4.
6. Gazi I, Boumpas D, Mikhailidis D, Ganotakis E. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol. 2007;25(1):102-11.
7. Kaplan M. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18(3):289-97.
8. Symmons D, Gabriel S. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE Nat Rev. Rheumatol. 2011;7:399-408.
9. Peters M, Symmons D, McCarey D, Dijkmans B, Nicola P, Kvien T, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325-31.
10. Stamatelopoulos K, Kitas G, Papamichael C, Chryssohoou E, Kyrkou K, Georgiopoulos G, et al. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol. 2009;29(10):1702-8.
11. van Halm V, Peters M, Voskuyl AE, Boers M, Lems WF, Visser M, et al. Rheumatoid arthritis versus type 2 diabetes as a risk factor for cardiovascular disease: a cross-sectional study. Ann Rheum Dis. 2009;68:1395-400.
12. John H, Toms TE, Kitas G. Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol. 2011;26(4):327-33.
13. Bartels C, Kind A, Everett C, Mell M, McBride P, Smith M. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. Arth Rheum. 2011;63(5):1221-30.
14. Soubrier M, Zerkak D, Dougados M. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem. J Rheumatol. 2006;33(9):1766-9.
15. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
16. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800-4.
17. Akkara Veetil B, Myasoedova E, Matteson E, Gabriel S, Crowson C. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol. 2013;40(7):1082-8.
18. Gomez-Vaquero C, Ruobustillo M, Narvaez J, Rodriguez-Moreno J, Gonzalez-Juanatey C, Llorca J, et al. Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index. Clin Rheumatol. 2012;31(1):35-9.
19. Rosales-Alexander JL, Salvatierra J, Llorca JM, C., González-Gay MA, Cantero-Hinojosa J, Raya-Álvarez E. Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index. Clin Exp Rheumatol 2014, Epub ahead.
20. Gómez-Vaquero C, Corrales A, Zacarías A, Rueda-Gotor J, Blanco R. SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(4):R91.
21. del Rincon I, Williams K, Stern M, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arth Rheum. 2001;44:2737-45.
22. Purcarea A, Sovaila S, Udrea G, Rezus E, Gheorghe A, Tiu C, et al. Utility of different cardiovascular disease prediction models in rheumatoid arthritis. J Med Life. 2014;7(4):588-94.
23. Kahlenberg J, Kaplan M. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med. 2013;64:249-63.
24. Solomon DH, Greenberg J, Curtis JR, Liu M, Farkouh ME, Tsao P, et al. Derivation and Internal Validation of an Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: A Consortium of Rheumatology Researchers of North America Registry Study. Arthritis Rheum. 2015;67(8):1995-2003.
25. Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, et al. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in medicare managed care plans. JAMA. 2011;305(5):480-6.
26. Solomon DH, Ayanian JZ, Yelin E, Shaykevich T, Brookhart MA, Katz JN. Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res (Hoboken). 2012;64(5):184-9.
27. Toms T, Panoulas V, Douglas K, Griffiths H, Sattar N, Smith J, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatmentof lipid-associated cardiovascular risk? Ann Rheum Dis. 2010;69(4):683-8.
28. De Vera M, Choi H, Abrahamowicz M, Kopec J, Lacaille D. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken). 2012;64(6):809-16.
29. De Vera M, Choi H, Abrahamowicz M, Kopec J, Goycochea-Robles M, Lacaille D. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2011;70(6):1020-4.
30. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, Epub ahead.